Publications

Jones R.B..  2017.  Antigen recognition-triggered drug delivery mediated by nanocapsule-functionalized cytotoxic T-cells.. Biomaterials. 117

Bronnimann MP, Skinner PJ, Connick E.  2018.  The B-Cell Follicle in HIV Infection: Barrier to a Cure.. Front Immunol. 9:20.

Avila-Rios S, Carlson JM, John M, Mallal S, Brumme ZL.  2019.  Clinical and evolutionary consequences of HIV adaptation to HLA: implications for vaccine and cure.. Curr Opin HIV AIDS. 14(3):194-204.

Pollack R.A..  2017.  Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape.. Cell Host Microbe. 21(4)

Clutton GTyndale, R Jones B.  2018.  Diverse Impacts of HIV Latency-Reversing Agents on CD8+ T-Cell Function: Implications for HIV Cure.. Front Immunol. 9:1452.

Macedo AB, Novis CL, De Assis CM, Sorensen ES, Moszczynski P, Huang S-H, Ren Y, Spivak AM, R Jones B, Planelles V et al..  2018.  Dual TLR2 and TLR7 agonists as HIV latency-reversing agents.. JCI Insight. 3(19)

Strongin Z, Sharaf R, D VanBelzen J, Jacobson JM, Connick E, Volberding P, Skiest DJ, Gandhi RT, Kuritzkes DR, O'Doherty U et al..  2018.  Effect of Short-Term Antiretroviral Therapy Interruption on Levels of Integrated HIV DNA.. J Virol. 92(12)

Osuna CE, Lim S-Y, Kublin JL, Apps R, Chen E, Mota TM, Huang S-H, Ren Y, Bachtel ND, Tsibris AM et al..  2018.  Evidence that CD32a does not mark the HIV-1 latent reservoir.. Nature. 561(7723):E20-E28.

Bachtel ND, Beckerle GA, Mota T, Rougvie Mde Mulder, Raposo RAndre, R Jones B, Nixon DF, Apps R.  2018.  Expression of host restriction factors by memory CD4+ T cells differs between healthy donors and HIV-1 infected individuals with effective ART.. AIDS Res Hum Retroviruses.

Cruz CRussell, Bollard CM.  2017.  HIV Receives a "One Two Knockout Punch".. Mol Ther. 25(3):566-567.

Bachtel ND, Umviligihozo G, Pickering S, Mota TM, Liang H, Del Prete GQ, Chatterjee P, Lee GQ, Thomas R, Brockman MA et al..  2018.  HLA-C downregulation by HIV-1 adapts to host HLA genotype.. PLoS Pathog. 14(9):e1007257.

Webb G.M..  2018.  The human IL-15 superagonist ALT-803 directs SIV-specific CD8(+) T cells into B-cell follicles.. Blood Adv.. 2(2)

Raposo R.A..  2017.  IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis.. JCI Insight. 2(1)

Macedo A.B..  2018.  Influence of Biological Sex, Age, and HIV Status in an In Vitro Primary Cell Model of HIV Latency Using a CXCR4 Tropic Virus.. AIDS Res Hum Retroviruses. 34(9)

Lin X..  2017.  Inhibition of HIV-1 infection in humanized mice and metabolic stability of protein phosphatase-1-targeting small molecule 1E7-03. . Oncotarget. 8(44)

Huang S.H..  2018.  Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells.. J Clin Invest. 128(2)

Pinzone MRita, D VanBelzen J, Weissman S, Bertuccio MPaola, Cannon LM, Venanzi-Rullo E, Migueles S, R Jones B, Mota T, Joseph SB et al..  2019.  Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion.. Nat Commun. 10(1):728.

Pinzone MRita, O'Doherty U.  2018.  Measuring integrated HIV DNA ex vivo and in vitro provides insights about how reservoirs are formed and maintained.. Retrovirology. 15(1):22.

Pinzone MRita, Graf E, Lynch L, McLaughlin B, Hecht FM, Connors M, Migueles SA, Hwang W-T, Nunnari G, O'Doherty U.  2016.  Monitoring Integration over Time Supports a Role for Cytotoxic T Lymphocytes and Ongoing Replication as Determinants of Reservoir Size.. J Virol. 90(23):10436-10445.

Anthony-Gonda K, Bardhi A, Ray A, Flerin N, Li M, Chen W, Ochsenbauer C, Kappes JC, Krueger W, Worden A et al..  2019.  Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model.. Sci Transl Med. 11(504)

Mujib S..  2017.  Pharmacologic HIV-1 Nef blockade promotes CD8 T cell-mediated elimination of latently HIV-1-infected cells in vitro.. JCI Insight. 2(17)

Jones B.R..  2018.  Phylogenetic approach to recover integration dates of latent HIV sequences within-host.. Proc Natl Acad Sci U S A. 115(38)

Bardhi A, Wu Y, Chen W, Li W, Zhu Z, Zheng JHua, Wong H, Jeng E, Jones J, Ochsenbauer C et al..  2017.  Potent NK Cell-Mediated Elimination of HIV-1-Infected Cells Mobilized by a gp120-Bispecific and Hexavalent Broadly Neutralizing Fusion Protein.. J Virol. 91(20)

Lin X..  2017.  Protein Phosphatase-1 -targeted Small Molecules, Iron Chelators and Curcumin Analogs as HIV-1 Antivirals.. Curr Pharm Des. 23(28)

Moroco JA, Alvarado JJeff, Staudt RP, Shi H, Wales TE, Smithgall TE, Engen JR.  2018.  Remodeling of HIV-1 Nef Structure by Src-Family Kinase Binding.. J Mol Biol. 430(3):310-321.